CEO OptInsight I We guarantee simplified and reliable HCP data, consent and preference management, allowing you to establish trust-based relationships with your targetgroup. Data integrity I Insights I (next best) Action
In the coming weeks I will share more tangible factors that drive consent collection rates in #pharma & #lifesciences, because we hear a lot of challenges in the market how to get consent. But first back to one of my favorites: The use of multiple channels in consent collection of HCPs. Is there a silver bullet for #consentcollection if you take into account that there are different communication channels? In the series of questions and answers regards consent management in #pharma & #lifesciences I continue with a new question. ❓ What is the most effective way to collect consent when different channels can be used (e.g #fieldforce, web portals, phone survey, webinars)? ↘ What we as OptInsight experience is that the phone channel results in high opt-in rates, sometimes up to 70% across countries. This has to do with the personal approach. Starting a personal dialogue with a doctor and/or assistant makes it possible to ask questions about their needs and wants. That makes it a powerful channel. It also counts for the sales rep channel, although we see lower rates. The main reason is that there is a need for more training to ask for consent during a call or meeting. For websites/portals we see ratios up to 60%, but that is highly dependent on how traffic is managed in these cases (e.g. marketing spend for advertising to attract HCPs to websites/portals). ▶ Moreover, the silver bullet is that you must put the channels in place where the HCP resides. It is not a question of deploying one channel, it is about #omnichannel engagement (on and offline). For more detailed info, you can also do a deep dive in our blog section https://lnkd.in/eF3gARuw
